Abstract
The severe shortage of donor hearts hampered the cardiac transplantation to patients with advanced heart failure. Therefore, cardiac regenerative therapies are eagerly awaited as a substitution. Human induced pluripotent stem cells (hiPSCs) are realistic cell source for regenerative cardiomyocytes. The hiPSC-derived cardiomyocytes are highly expected to help the recovery of heart. Avoidance of teratoma formation and large-scale culture of cardiomyocytes are definitely necessary for clinical setting. The combination of pure cardiac spheroids and gelatin hydrogel succeeded to recover reduced ejection fraction. The feasible transplantation strategy including transplantation device for regenerative cardiomyocytes are established in this study.
Original language | English |
---|---|
Pages (from-to) | 239-254 |
Number of pages | 16 |
Journal | JACC: Basic to Translational Science |
Volume | 6 |
Issue number | 3 |
DOIs | |
Publication status | Published - 03-2021 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine